In terms of treatment type, 41.6% of participants were managing their diabetes using oral hypoglycemic agents (OHA), 24.4% were using a combination of OHA and insulin, 21.8% relied on lifestyle modifications, and 12.2% were on insulin injections alone. This evidence concerns the gene INS and diabetes mellitus.